In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study

PLoS One. 2016 Apr 28;11(4):e0154024. doi: 10.1371/journal.pone.0154024. eCollection 2016.

Abstract

Introduction: Recent efforts to increase CRT response by multiSPOT pacing (MSP) from multiple bipols on the same left ventricular lead are still inconclusive.

Aim: The Left Ventricular (LV) MultiSPOTpacing for CRT (iSPOT) study compared the acute hemodynamic response of MSP pacing by using 3 electrodes on a quadripolar lead compared with conventional biventricular pacing (BiV).

Methods: Patients with left bundle branch block (LBBB) underwent an acute hemodynamic study to determine the %change in LV+dP/dtmax from baseline atrial pacing compared to the following configurations: BiV pacing with the LV lead in a one of lateral veins, while pacing from the distal, mid, or proximal electrode and all 3 electrodes together (i.e. MSP). All measurements were repeated 4 times at 5 different atrioventricular delays. We also measured QRS-width and individual Q-LV durations.

Results: Protocol was completed in 24 patients, all with LBBB (QRS width 171±20 ms) and 58% ischemic aetiology. The percentage change in LV+dP/dtmax for MSP pacing was 31.0±3.3% (Mean±SE), which was not significantly superior to any BiV pacing configuration: 28.9±3.2% (LV-distal), 28.3±2.7% (LV-mid), and 29.5±3.0% (LV-prox), respectively. Correlation between LV+dP/dtmax and either QRS-width or Q-LV ratio was poor.

Conclusions: In patients with LBBB MultiSPOT LV pacing demonstrated comparable improvement in contractility to best conventional BiV pacing. Optimization of atrioventricular delay is important for the best performance for both BiV and MultiSPOT pacing configurations.

Trial registration: ClinicalTrials.gov NTC01883141.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bundle-Branch Block / physiopathology
  • Bundle-Branch Block / therapy*
  • Cardiac Pacing, Artificial / methods*
  • Female
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Hemodynamics*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Ventricular Function, Left*

Grants and funding

Funding for this research was provided by Medtronic, Inc., Bakken Research Center (BRC), Maastricht, The Netherlands, USA. BRC’s clinical department ran the multi-center clinical trial that was used to develop this manuscript. Medtronic provided the statistician and database management for the execution of the trial. Medtronic facilitated the advisory panel in the development of the trial and provided guidance for the manuscript preparation and submission process. Medtronic will also assist with any publication fees incurred. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.